2013Zhongguo jiceng yiyaoRequires access

Influence of different doses of atorvastatin on the blood lipids and cardiac ischemic events after percutaneous coronary intervention in patients with coronary heart disease

Bai Zhifeng

Open publisher page 0 citations

Abstract

Objective To observe the influence of different doses of atorvastatin on the hyperlipidemia and cardiac ischemic events after percutaneous coronary intervention (PCI) in patients with coronary heart disease (CHD).Methods 132 cases with CHD in our hospital were randomly divided into group A,group B and group C,and they were given different doses of atorvastatin after the PCI surgery,.The changes of lipid levels and cardiac ischemic events were compared.Results TC,TG and LDL-C levels in the three groups were significantly decreased after treatment,and the HDL-C level significantly increased (P < 0.05),TC and LDL-C of group B and group C were significantly lower(P < 0.05).The cardiac ischemic events and the incidence rate of a variety of adverse reactions of group C were less than group A and group B,but the differences were not significant (P > 0.05).Conclusion Highdose atorvastatin (40mg) can effectively decrease blood lipid levels in CHD patients after PCI,reduce the incidence rate of cardiac ischemic events,and it is safe,effective,which is worth to be promoted and applicated in clinical. Key words: Atorvastatin;  Percutaneous coronary intervention;  Blood lipids;  Cardiac ischemic events

About this research paper

What this paper is about

Objective To observe the influence of different doses of atorvastatin on the hyperlipidemia and cardiac ischemic events after percutaneous coronary intervention (PCI) in patients with coronary heart disease (CHD).Methods 132 cases with CHD in our hospital were randomly divided into group A,group B and group C,and they were given different doses of atorvastatin after the PCI surgery,.The changes of lipid levels and cardiac ischemic events were compared.Results TC,TG and LDL-C levels in the three groups were significantly decreased after treatment,and the HDL-C level significantly increased (P < 0.05),TC and LDL-C of group B and group C were significantly lower(P < 0.05).The cardiac ischemic events and the incidence rate of a variety of adverse reactions of group C were less than group A and group B,but the differences were not significant (P > 0.05).Conclusion Highdose atorvastatin (40mg) can effectively decrease blood lipid levels in CHD patients after PCI,reduce the incidence rate of cardiac ischemic events,and it is safe,effective,which is worth to be promoted and applicated in clinical. Key words: Atorvastatin;  Percutaneous coronary intervention;  Blood lipids;  Cardiac ischemic events

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe the influence of different doses of atorvastatin on the hyperlipidemia and cardiac ischemic events after percutaneous coronary intervention (PCI) in patients with coronary heart disease (CHD).Methods 132 cases with CHD in our hospital were randomly divided into group A,group B and group C,and they were given different doses of atorvastatin after the PCI surgery,.The changes of lipid levels and cardiac ischemic events were compared.Results TC,TG and LDL-C levels in the three groups were significantly decreased after treatment,and the HDL-C level significantly increased (P < 0.05),TC and LDL-C of group B and group C were significantly lower(P < 0.05).The cardiac ischemic events and the incidence rate of a variety of adverse reactions of group C were less than group A and group B,but the differences were not significant (P > 0.05).Conclusion Highdose atorvastatin (40mg) can effectively decrease blood lipid levels in CHD patients after PCI,reduce the incidence rate of cardiac ischemic events,and it is safe,effective,which is worth to be promoted and applicated in clinical. Key words: Atorvastatin;  Percutaneous coronary intervention;  Blood lipids;  Cardiac ischemic events

Key concepts: Medicine, Atorvastatin, Conventional PCI, Percutaneous coronary intervention, Cardiology, Internal medicine, Blood lipids, Hyperlipidemia

Related papers

Back to paper searchBrowse research topicsOriginal source
Influence of different doses of atorvastatin on the blood lipids and cardiac ischemic events after percutaneous coronary intervention in patients with coronary heart disease — Research Paper | ScholarLens